Infections

All Conditions

Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Symptoms and General Pathology

Skin and Connective Tissue Diseases

Mouth and Tooth Diseases

Ear, Nose, and Throat Diseases

Papilloma

Uterine Cervical Neoplasms

Communicable Diseases

Virus Diseases

Papillomavirus Infections

Warts

Condylomata Acuminata

Oropharyngeal Neoplasms

Disease Attributes

Urogenital Diseases

Genital Diseases

Neoplasms, Squamous Cell

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Pharyngeal Neoplasms

Otorhinolaryngologic Neoplasms

Head and Neck Neoplasms

Pharyngeal Diseases

Stomatognathic Diseases

Otorhinolaryngologic Diseases

Sexually Transmitted Diseases

Sexually Transmitted Diseases, Viral

DNA Virus Infections

Skin Diseases

Skin Diseases, Viral

Tumor Virus Infections

Skin Diseases, Infectious

All Drugs and Chemicals

Vaccines

The clinical team will be left to identify the need for a follow-up HPV vaccine through existing mechanisms

A simple reminder prompt in which CHICA will provide an immunization reminder to the physician that the child is eligible for the 2nd or 3rd dose of vaccine.

Simple Reminder

Gregory D Zimet, PhD

Randomized, 2-arm observational study. The 2 arms (randomized at the level of health care provider) will be: 1. usual practice; 2. automated reminders to recommend 2nd and 3rd doses of HPV vaccine for eligible male and female adolescents who have initiated vaccination.

The study team plans to conduct a randomized clinical trial with three arms: (1) usual care, (2) the simple reminder, and (3) the simple reminder plus the script. Randomization will be carried out at the physician level at each clinical site, to ensure that all three treatment arms are represented in each clinic. The primary outcome, HPV vaccine acceptance, will be assessed for each study participant.

This study will be implemented through the Child Health Improvement through Computer Automation system (CHICA). CHICA is a computer based clinical decision support system that has been operating in the Wishard/Eskenazi system since 2004. CHICA now operates in 5 clinics in the health system and has served well over 37,000 children. CHICA supports primary pediatric care, supporting screening, counseling, anticipatory guidance, vaccinations, and chronic disease diagnosis and management.

CHICA is unique in several respects. These include a unique tailored, scannable paper interface, a prioritization scheme that assures the highest priority reminders are given to physicians, and the ability to collect data directly from families in the waiting room. CHICA acts as a front end to the Regenstrief Medical Record System (RMRS), the electronic medical record for the Eskenazi health system. The RMRS and CHICA communicate using industry standard HL7 communication protocols.

When a patient checks into a CHICA clinic, CHICA receives an HL7 ADT (registration) message. In response CHICA requests a download of the patient's record from the RMRS. CHICA applies a set of Arden Syntax rules to the patient's data to select 20 yes/no questions that are printed. The family answers these questions by checking boxes. The nurse or medical assistant enters height, weight, etc. on the same form and the form is scanned. The data enter CHICA's database through optical mark recognition and optical character recognition. Recently we have begun converting from this scannable paper format to electronic tablets.

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Individual provider data will not be made available.

To evaluate the rate of physician-targeted automated HPV vaccination reminders on 2nd and 3rd dose HPV vaccination rates among 11-17 year old male and female patients who have received 1 or 2 doses of vaccine.

The study team will compare changes in vaccination rates with qualitative feedback from providers.

Merck Sharp & Dohme LLC

Indiana University

Regenstrief Institute, Inc.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3	NCT02558803	Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... Cervical Cancer Genital Warts Oropharyngeal C...	Simple Reminder	11 Years - 17 Years	Regenstrief Institute, Inc.
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3	NCT02558803	Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... Cervical Cancer Genital Warts Oropharyngeal C...	Simple Reminder	11 Years - 17 Years	Regenstrief Institute, Inc.

Spots Global Cancer Trial Database for quadrivalent vaccine